3
Announcements
Trials
Browse
Landscape
Phase
Phase 3
1
Status
Recruiting
1
Completed
1
Sponsor Class
OTHER
1
Study Type
Interventional
1
Sponsor
Cancer Type
Lymphoid
1
Conditions
Thrombosis
1
Lymphoma, Follicular
1
Ischemic Stroke
1
Cancer-associated Thrombosis
1
Interventions
apixaban
3
Warfarin
2
Dalteparin
2
Aspirin
2
salicylhydroxamic acid
1
fluorescein isothiocyanate-keyhole limpet hemocyanin
1
edoxaban
1
Simvastatin
1
Rivaroxaban
1
Radiotherapy, Conformal
1
Paclitaxel
1
Observation
1
Injections
1
Fondaparinux
1
Enoxaparin
1
Docetaxel
1
Data Collection
1
Dabigatran
1
Clopidogrel
1
Arginine Vasopressin
1
Arginine
1
Anticoagulants
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Completed
×
Thrombosis
×
Anticoagulants
×
Clear all
NCT05507645
2024-09-05
PUMICE
Beijing Tiantan Hospital
Phase 3
Completed
1,446 enrolled